OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies
Phase 4 Head-to-Head Study in Patients with Stage 3 or 4 Chronic Kidney Disease Phase 2 Trial in Patients with Stage 5 Chronic Kidney Disease on Dialysis MIAMI, March 25, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today reported interim …